Make, Buy Or Partner: Strategic Alliances Continue To Fuel Biopharma Growth

 

Published in In Vivo, November 2021

Authors: Dr. Nicholas Frame and Dr. Oded Ben-Joseph

Abstract:

The biopharma market has been highly active throughout the COVID-19 pandemic with a substantial focus on strategic alliances between 2020-H1 2021. Partnership deals present exciting liquidity and risk mitigation opportunities for early-stage companies. Small molecules still comprise the largest segment of partnered drugs, but alliances for other modalities are on the rise.

View full article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    99 High St. Suite 2900, Boston, MA 02110
    (617) 431-4886